Sunzen Biotech Berhad Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SUNZEN?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	21,954,800	2.82%
Public Companies	33,041,600	4.25%
General Public	282,245,857	36.3%
Individual Insiders	440,541,596	56.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.3%.

Top Shareholders

Top 25 shareholders own 61.86% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.2%	Yek Teo	118,506,908	RM 37.9m	-13.3%	no data
4.88%	Mun-Cuan Chum	37,930,915	RM 12.1m	0%	no data
4.25%	JAG Berhad	33,041,600	RM 10.6m	168%	no data
4.2%	Kim Lian Chen	32,700,950	RM 10.5m	0%	no data
4.11%	Khai Voon Chen	32,000,000	RM 10.2m	0%	no data
3.55%	Ah Hock Kuan	27,636,000	RM 8.8m	0%	no data
3.34%	Wooi Huat Teow	25,972,772	RM 8.3m	0%	no data
2.82%	Global Mines Services Sdn Bhd	21,954,800	RM 7.0m	136%	no data
1.99%	Weng Seng Koo	15,442,500	RM 4.9m	-14.2%	no data
1.73%	Shy Ming Teoh	13,488,900	RM 4.3m	0%	no data
1.68%	Chee Chow Teow	13,047,700	RM 4.2m	4.07%	no data
1.42%	Tiam Hock Chang	11,080,500	RM 3.5m	0%	no data
1.41%	Chee Hua Lee	11,000,000	RM 3.5m	0%	no data
1.29%	Seng Lee Lim	10,000,000	RM 3.2m	0%	no data
1.29%	Kok Foong Goh	10,000,000	RM 3.2m	0%	no data
1.29%	Wai Kong Wu	10,000,000	RM 3.2m	0%	no data
1.17%	Su Lang Chien	9,135,700	RM 2.9m	0%	no data
0.95%	Chee Yeap Low	7,355,739	RM 2.4m	0%	no data
0.87%	Wei Kent Tan	6,801,000	RM 2.2m	0%	no data
0.79%	Hong Ping Huam	6,109,300	RM 2.0m	0%	no data
0.77%	Pei Fern Wong	6,000,000	RM 1.9m	-8.74%	no data
0.75%	Yoong Chang Go	5,823,000	RM 1.9m	0%	no data
0.7%	Min Lin Ng	5,452,400	RM 1.7m	0%	no data
0.69%	Wei Foon Lim	5,377,500	RM 1.7m	0%	no data
0.68%	Kian Sun Choong	5,296,600	RM 1.7m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 17:40
End of Day Share Price	2024/12/19 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sunzen Biotech Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution